title: Rebranding of generic parenteral vasopressin: Effect on clinician practices and perceptions.
authors.affiliation: School of PharmacyNortheastern UniversityBoston, MA.
authors.forename: Nicole
authors.initials: N
authors.lastname: Curtis
authors.affiliation: School of PharmacyNortheastern UniversityBoston, MA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Corapi
authors.affiliation: Department of Pharmacy ServicesMassachusetts General HospitalBoston, MA.
authors.forename: Russel
authors.initials: R
authors.lastname: Roberts
authors.affiliation: School of PharmacyNortheastern UniversityBoston, MAj.devlin@neu.edu.
authors.forename: John W
authors.initials: JW
authors.lastname: Devlin
mesh_terms: D016568:Drugs, Generic / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D010818:Practice Patterns, Physicians'; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*; D014667:Vasopressins / Q000008:administration & dosage*
chemical_list: D016568:Drugs, Generic; D014662:Vasoconstrictor Agents; D014667:Vasopressins
keywords: drug cost; generic rebranding; intensive care; severe sepsis; vasopressin